Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-15-007647
Filing Date
2015-12-15
Accepted
2015-12-15 17:24:32
Documents
36
Period of Report
2015-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K bkit_10k.htm 10-K 222827
2 CERTIFICATION bkit_ex31.htm EX-31 7582
3 CERTIFICATION bkit_ex32.htm EX-32 3086
10 img001.jpg GRAPHIC 20491
  Complete submission text file 0001477932-15-007647.txt   979196

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT bkit-20150831.xml EX-101.INS 82439
5 XBRL TAXONOMY EXTENSION SCHEMA bkit-20150831.xsd EX-101.SCH 14866
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bkit-20150831_cal.xml EX-101.CAL 20532
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bkit-20150831_def.xml EX-101.DEF 16026
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bkit-20150831_lab.xml EX-101.LAB 85145
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bkit-20150831_pre.xml EX-101.PRE 66369
Mailing Address 244, 5TH AVENUE, SUITE A154 NEW YORK NY 10001
Business Address 244, 5TH AVENUE, SUITE A154 NEW YORK NY 10001 980-254-1842
Blake Insomnia Therapeutics, Inc. (Filer) CIK: 0001556416 (see all company filings)

EIN.: 460780380 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55022 | Film No.: 151289296
SIC: 7200 Services-Personal Services